Published By : 28 Jan 2016 | Published By : QYRESEARCH
Digital pathology is an emerging technology which offers significant improvement across various applications such as diagnostic tests, drug discovery and development, and academic and research purposes. Developments in information technology and increasing favourable healthcare reforms have propelled the growth of the global digital pathology systems market. In addition, increasing workload of pathologists and rising healthcare spending has fuelled the demand for digital pathology systems. However, high initial setup cost, sampling error, and stringent regulatory compliance might delay the approval process of these systems, thereby reducing the adoption of digital pathology systems.
New Technique to Offer High-Resolution Digital Microscopy Images
Researchers at the California NanoSystems Institute have developed a new technique to enhance the quality of digital microscopy images, thereby improving the resulting disease diagnoses. The new development might prove as a significant step for the production of digital imagery in microscopy. So far, digital imagery in microscopy has often led to blurry and pixilated images.
The new method, termed as wavelength scanning pixel super-resolution, captures a number of digital images of the same sample at different wavelengths of light. The captured pixels in each of the images are broken down into smaller pixels, thus producing a much higher-resolution digital image of the examined specimen.
First FDA-Approved Digital Pathology System Might Develop Soon
So far, manufacturers have not been able to comply with the stringent regulatory requirements set by the U.S. Food and Drug Administration (FDA) regarding the approval of digital pathology systems. However, the future looks positive with the following developments: